BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 4370990)

  • 1. Depression of cell-mediated immunity during acute infectious mononucleosis.
    Mangi RJ; Niederman JC; Kelleher JE; Dwyer JM; Evans AS; Kantor FS
    N Engl J Med; 1974 Nov; 291(22):1149-53. PubMed ID: 4370990
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers.
    Pattengale PK; Smith RW; Perlin E
    N Engl J Med; 1974 Nov; 291(22):1145-8. PubMed ID: 4138509
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I; Sullivan JL; Periman PO; Perlin E
    N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subpopulations and reactivity during and after infectious mononucleosis.
    Lumio J; Welin MG; Hirvonen P; Weber T
    Med Biol; 1983; 61(4):208-13. PubMed ID: 6317995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T- and B-lymphocyte determination in infectious mononucleosis].
    Sauer O
    Fortschr Med; 1977 Jun; 95(23):1506-8. PubMed ID: 328360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T and B lymphocytes in peripheral blood of children with infectious mononucleosis and tonsillitis.
    Resková D; Kubiková A; Macku M
    Acta Paediatr Acad Sci Hung; 1980; 21(1):27-31. PubMed ID: 6255733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epstein-Barr virus and its role in various rheumatic diseases].
    Anan'eva LP; Alekberova ZS; Barinskii IF; Nasonova VA
    Ter Arkh; 1983; 55(7):140-6. PubMed ID: 6312625
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated immunity in acute infectious mononucleosis.
    Royston I; Sullivan JL; Periman PO; Perlin E
    Bibl Haematol; 1975 Oct; (43):278-80. PubMed ID: 183684
    [No Abstract]   [Full Text] [Related]  

  • 9. Control mechanisms in infectious mononucleosis.
    Denman AM; Pelton BK
    Clin Exp Immunol; 1974 Sep; 18(1):13-25. PubMed ID: 4377556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity of Epstein-Barr virus in Hodgkin's disease preceded by infectious mononucleosis.
    Band PR; Levine PH; Patwardhan VC; Shnitka TK; Pabst HF
    Can Med Assoc J; 1973 Jan; 108(2):183-6. PubMed ID: 4346314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodeficiency in Hodgkin disease.
    Eltringham JR; Kaplan HS
    Birth Defects Orig Artic Ser; 1975; 11(1):278-88. PubMed ID: 1148383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the clinical manifestations, laboratory findings, and complications of infectious mononucleosis.
    White LR; Karofsky PS
    Wis Med J; 1985 Dec; 84(12):19-25. PubMed ID: 3002047
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Epstein-Barr virus and infectious mononucleosis.
    Royston I
    Lancet; 1973 Nov; 2(7838):1152. PubMed ID: 4128043
    [No Abstract]   [Full Text] [Related]  

  • 14. Five-year prospective studies of the dynamics of B, T and null lymphocyte cell count in infectious mononucleosis.
    Janeczko J
    Acta Med Pol; 1985; 26(3-4):153-66. PubMed ID: 3879785
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
    Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA
    J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical assessment of T and B lymphocyte functions.
    Farnes P
    R I Med J (1976); 1976 Feb; 59(2):51-6, 71. PubMed ID: 1082619
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal infectious mononucleosis in a family.
    Bar RS; DeLor CJ; Clausen KP; Hurtubise P; Henle W; Hewetson JF
    N Engl J Med; 1974 Feb; 290(7):363-7. PubMed ID: 4358992
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.